Galapagos NV American Depositary Shares (GLPG)

FairStock Score: 88/100 — HIGH CONVICTION

Key Financials

Strengths

• Generates $345 million in annual free cash flow (17.8% yield on market cap)
• Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
• Solid return on equity of 10.4% above cost of capital
• Conservative balance sheet with debt-to-equity of just 0.00, providing financial flexibility
• Altman Z-Score of 8.9 confirms minimal bankruptcy risk and strong solvency

AI Analysis

Galapagos NV American Depositary Shares is a micro-cap healthcare company valued at $1.9 billion. The business generates $1.1 billion in annual revenue with a 70.3% net margin and $345 million in free cash flow. From a quality standpoint, Galapagos shows solid Piotroski F-Score of 7/9 and Altman Z-Score of 8.9 confirms fortress-level solvency. On valuation, the stock is deeply undervalued on a P/E basis at 5.0x, with offers a 64% margin of safety vs Graham Number of $79. Growth dynamics show revenue growing at 1093.2% and profit growth of 2990.6%. Our composite FairStock Score of 88/100 reflects strong fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Galapagos's 1093% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $345 million in annual free cash flow (17.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer